Literature DB >> 25623193

Frailty syndrome - Medicolegal considerations.

Roger W Byard1.   

Abstract

The frailty syndrome refers to the concurrence of a number of specific clinical manifestations that include unintentional weight loss, decreased muscle mass (sarcopenia), exhaustion, reduced physical strength and activity, and slow ambulation. It involves multiple systems, is an increasing problem in elderly populations, and is strongly associated with increases in both morbidity and mortality. Despite its recognition clinically, the frailty syndrome is not often identified in forensic situations and is only infrequently mentioned in the associated literature. As there is a direct relationship between the frailty syndrome and significant adverse health outcomes the syndrome has clear medicolegal significance.
Copyright © 2015 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.

Entities:  

Keywords:  BMI; Exhaustion; Frailty syndrome; Hypothermia; Sarcopenia; Weakness

Mesh:

Year:  2015        PMID: 25623193     DOI: 10.1016/j.jflm.2014.12.016

Source DB:  PubMed          Journal:  J Forensic Leg Med        ISSN: 1752-928X            Impact factor:   1.614


  3 in total

1.  Anaphylaxis at autopsy.

Authors:  Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2016-08-29       Impact factor: 2.007

2.  Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Authors:  Osamu Soma; Shingo Hatakeyama; Teppei Okamoto; Naoki Fujita; Teppei Matsumoto; Yuki Tobisawa; Tohru Yoneyama; Hayato Yamamoto; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Shigeyuki Nakaji; Chikara Ohyama
Journal:  Oncotarget       Date:  2018-04-03

3.  Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.

Authors:  Tendo Sato; Shingo Hatakeyama; Teppei Okamoto; Hayato Yamamoto; Shogo Hosogoe; Yuki Tobisawa; Tohru Yoneyama; Eiji Hashiba; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Kazuyoshi Hirota; Chikara Ohyama
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.